Bristol-Myers Squibb (NYSE: BMY) has promoted Christopher Boerner to chief commercial officer. Boerner had been head of Bristol’s U.S. commercial organization, a post he has held since joining the New York-based pharmaceutical giant in 2015. His experience also includes positions at Seattle Genetics (NASDAQ: SGEN), Dendreon, and Genentech. Boerner succeeds Murdo Gordon, who left Bristol earlier this month to join Amgen (NASDAQ: AMGN) as executive vice president of global commercial operations.
UNDERWRITERS AND PARTNERS